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Introduction
T
here are some popular beliefs in commercial 
poultry production that always require 
justification. Certainly the first is the 
assumption by lay people that the rapid 
growth and precocity of broilers, as well as the high 
rate of egg production by the laying hens, must 
the result of exogenous hormones. Considering 
that even in the poultry business arena there are 
professionals whose technical background is not 
related to biology, we better start doing our home 
work making it clear about the truth. Are there 
hormones involved in poultry production and is 
there a technical reason that would justify the use 
of exogenous hormones? Why do broilers grow so 
fast? 
Another area that affects us all is the relationship 
that has been assumed between egg consumption 
and the levels of cholesterol in blood, and thus 
related to cardiovascular disease problems. This has 
been a reason to keep even poor people away from 
egg consumption, besides being a low price and 
one of the most complete and nutritiously balanced 
foods. What is true about this?
Finally, and this is a more recent event, most of 
human nutritionists and health related professionals 
do recommend organic or any kind of alternative 
poultry product, arguing that these foods are both, 
healthier and more nutritious. Is there any evidence 
in the literature that supports such believing?
There are a great number of reviews in the 
literature in any of these themes, but in general 
they are addressed to technical specialists, thus 
containing details that make the comprehension 
difficult for lay people. This manuscript is an attempt 
to bring this issue to an easy understanding and help 
you to get answer for every-day ordinary questions. 
Is there any advantage by 
using exogenous hormones 
in chickens?
The interaction of various endogenous and 
exogenous factors drives the way tissues grow and 
change the body weight of poultry. While nutrition 
and housing are important exogenous factors, 
the limit of the growth process is determined by 
the endogenous factors. Hormones are chemical 
substances secreted into organic fluids by the cells, 
with the function of drive the physiologic control at 
other cells or organs. These endogenous substances 
are essential components needed for the regulation, 
biosynthesis, and metabolism of muscle proteins.
Chemically, the most important hormones 
evaluated as possible growth enhancers are the 
sex steroids, thyroid hormones, and peptides from 
the somatotropic axis. Steroids have a chemical 
structure based on the sterol nucleus, similar to 
cholesterol and in general derived from it. In this 
group are the gonad hormones such as testosterone, 
progesterone, and estrogen. Thyroid hormones are 
tyrosine-derived (tiroxine, T4 and triodotiroxine, T3) 
while peptides are the somatotropic substances 
which considers the Growth Hormone (GH) and its 
related factors as the Insulin-like Growth Factors 
(IGF I and IGF II) and the Growth Hormone Releasing 
Factor (GHRF).
It is important to consider that amino acids, which 
are usually marketed for human consumption as 
a muscle propeller, are not hormones, but simple 
nutrients. Once ingested, they are absorbed in 
the intestine and, via blood flow, will reach a site 
where the nutrient role will be fulfilled. This is 
also the case of other substances such as vitamins 
and minerals. All these nutrients are also used in 
poultry nutrition.
Researchers at Embrapa Swine and Poultry, Brazil
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Usually, when people hear how rapidly broiler 
chickens grow or how many eggs a layer produces, 
it is a general belief that something not legal, a 
“magic bullet”, is being used. The major assumption 
is that some kind of exogenous hormones, besides 
the normal circulating endogenous substances, 
would be used. Although some efforts have been 
made to address this issue, as Penz (2012) in 
Brazil and Anderson & Gernat (2004) in the USA, 
in order to strengthen the discussion, we revisited 
the literature to review some studies, most realized 
in the eighties and nineties, which analyzed the 
technical possibilities of obtain advantages by the 
use of exogenous hormones.
Sex steroids
Studies evaluating the use of sex steroids in 
poultry are less frequent than in mammals and 
have met with much little success than those. In 
a study of Fennell & Scanes (1992), the utilization 
of three different androgens (testosterone, 
5-dihydrotestosterone and 19-nortestosterone) 
implanted subcutaneously in leghorns (males, 
females, and castrated males) in general reduced 
body weight gain. There was no stimulus to growth 
of any of the substances evaluated. In fact as early 
as in 1948 it was observed that androgen, in both 
natural or synthetic forms, inhibits growth of broilers 
(Turner, 1948; Visco, 1973; Harvey & Scanes, 1978). 
What in fact happens with the use of androgens 
is a marked development of secondary male 
characteristics (Dube & Trembley, 1974; Fennel & 
Scanes, 1992). 
Worries about supposed high ingested levels 
of steroid hormones through food are usually 
expressed on television by human nutritionists or 
even physicians. In order to evaluate the contribution 
of daily ingestion, a Germany team (Hartman et al., 
1998) compared the secreted steroid hormones in 
humans to the estimated intake of these substances 
contained in food, based on a survey of the natural 
occurrence of steroid hormones in human nutrition. 
The intake of any of the hormones rarely reaches 
6% of the naturally produced in the human body. 
When it comes specifically to meat (including 
chicken), which usually is the main concern, the 
authors concluded that: 
“Meat does not play a dominant role in 
the daily intake of steroid hormones. More 
effects on human beings can be expected 
from exposure to phytoestrogens, which occur 
in plants in high amounts, or by environmental 
chemicals with hormonal or hormone blocking 
activity such as polychlorinated biphenyls or 
dioxines, which are widespread in food and 
water” (Hartmann et al., 1998).
Therefore, it seems that many people are looking 
for the danger in the wrong place. 
Growth Hormone 
By far the focus of research related to poultry 
growth stimulus by hormones relied on studies 
evaluating the exogenous use of substances from 
the somatotropic axis. Growth hormone (GH) is 
required for normal posthatching growth, as lack of 
it resulting from hypophysectomy is followed by a 
dramatic decrease in the growth rate of chickens, 
whereas GH replacement restores growth to a great 
extent (King & Scanes, 1986). The somatotrophs 
are peptides, therefore cannot be used orally once 
would be degraded by gastrointestinal digestion. 
Furthermore, special attention to the injection or 
infusion procedure should be taken, since, according 
to the literature, it should be in pulsatile frequencies 
in order to mimic the natural process (Vasilatos-
Younken et al., 1988). This by itself would implicate 
in application difficulties when we consider that 
billions of chickens are grown annually in Countries 
like the USA or Brazil. However, the main limitation 
is the lack of real performance advantage data that 
would justify the use of exogenous GH. 
An interesting way to study the effect of 
different growth factors is using contrasting models 
like fast growth rate broiler chickens, light body 
weight gain pullets or dwarf chickens. Goodard et 
al., (1988) made such comparison with broilers and 
white leghorns based on plasma concentrations 
of IGF-I, GH, thyroid hormones and insulin. 
Interestingly, heaviest lines always have the lowest 
concentration of plasma GH. However, the negative 
relationship between growth rate and plasma GH 
concentration only occurs when fast-growing lines 
and slow-growing lines of poultry are compared, 
as observed for turkeys (Proudman & Wentworth, 
1980), chickens (Burke & Marks, 1982; Goodard et 
al., 1988) and Japanese quail (Bacon et al., 1987). 
Such relationships get more complex when different 
genders are involved. 
Growth control by hormones is not only 
dependent on interactions between hormones 
themselves but is totally dependent on the 
presence of receptors. These receptors occur on cell 
membranes, in the cytoplasm, and in the nuclei of 
the cells. It is known that there are slow growing 
dwarf chickens that lack the GH receptors (Burnside 
et al., 1992; Agarwal et al., 1994).
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Studies with exogenous GH were performed 
using both natural or recombinant peptides. 
Initially, the evaluated GH usually was originated 
from bovine. According to Scanes et al., (1984), the 
effect of bovine GH on growth in intact broilers, 
turkeys, and ducks has been extensively studied, 
showing ineffectiveness to stimulate post hatching 
growth in poultry. Although it might indicate no 
activity of this hormone because of its bovine origin, 
previous studies related by the authors show activity 
of the bovine GH in hypophysectomised chickens. 
The use of chicken GH of both from natural or 
recombinant origin in intact broiler chickens was 
evaluated by Cogburn et al., (1989). The substances 
were daily injected subcutaneously, for 14 days 
starting at 21 days o age, using doses of 100 or 
200 µg/kg BW, the activity of the compounds 
being previously confirmed on essays with 
hypophysectomised rats. The study showed no effect 
on metabolic indicators (plasmatic levels of IGF-I, 
thyroid hormones, insulin, glucagon and glucose) 
and, although without effect on body weight, use 
of GH increased corporal fat. After exhaustive data 
analysis, the authors concluded that the “in vivo 
study clearly showed that daily injections of GH 
in broiler chickens has no benefic effect on body 
weight or on meat yield” (Cogburn et al., 1989). In 
a similar study, Burke et al., (1987) injected chicken 
recombinant GH (crGH) in a daily basis from 2 to 24 
days of age. No effect on body weight was observed 
leading the authors to conclude that “several lines 
of evidence in this study indicate that rcGH is 
biologically active in chickens, but it clearly does 
not promote growth in normal, rapidly growing 
broilers”. Vasilatos-Younken et al., (1988), working 
with 8-week-old broiler-strain pullets, injected cGH, 
but in a 90-minute interval for 21 consecutive days. 
The authors observed significant positive effect 
on feed efficiency, bone longitudinal growth and 
weight, and fat reductionAnyway, according to 
Vasilatos-Younken et al., (1999), based on own data 
and on a extend review, “in general, exogenous 
GH administration using both recombinant and 
pituitary-derived homologous preparations, have 
failed to improve somatic growth, and, in particular, 
skeletal muscle deposition, in pituitary-intact 
domestic poultry”. The same authors reported a 
study with different recombinant chicken GH (cGH) 
administration to female-strain chickens at late post-
hatch age (8 to 9 weeks, when endogenous GH 
secretion is relatively low). Each dose was delivered 
daily by intravenous infusion in 16 pulses to mimic 
the normal endogenous pattern. The conclusion of 
Vasilatos-Younken et al., (1999) was that, 
“in contrast to the positive effects of 
exogenous GH on BW in mammals, cGH 
administered to late post-hatch broiler-strain 
chickens reduced body weight gain in a dose-
dependent manner, with a maximal depression 
(34%) at the highest dosage administered 
(200 µg/kg/day)”. 
Attempts have also been made with other 
related factors of the somatotropic axis. Moellers 
& Cogburn (1994) evaluated pulsatile infusion of 
growth hormone-releasing factor (GRF), which is 
a secretagogue of GH, thus enhancing plasma GH 
levels. The study showed that GRF did not improve 
growth rate, feed efficiency or body composition of 
young chickens. Similar studies were conducted with 
IGF-I, whose synthesis and secretion is tightly coupled 
to the pulsatile pattern of circulating GH, showing 
that there is no growth-promoting effects on intact 
normal growing chickens (Buyse & Decuypere, 
1999). There are several exhaustive reviews in this 
issue (McMurtry, et al., 1997; Vasilatos-Younken, 
1999; Buyse & Decuypere, 1999; Scanes, 2009), all 
reaching similar conclusions about a possible effect 
on broiler posthach performance. 
Considering that in ovo injection could be of 
practical importance in case of positive result, Dean 
et al., (1993) evaluated in ovo injection of bovine 
recombinant GH using chicken eggs at day 11 of 
incubation. After detailed BW and metabolic data 
analysis and discussion, the authors suggested that 
“GH is not directly involved in somatic growth of young 
rapidly growing chickens”. Some years later, Kocamis 
et al., (1998) reported a study were in ovo injection 
of recombinant human IGF-I seemed to show some 
promise, what however has not been further explored. 
Thyroid Hormones
The importance of the thyroid hormones on 
muscle development has been observed long ago 
through the induced hypothyroidism produced by 
injection of propylthioracil (King & King, 1973) or by 
physically thyroidectomizing the chickens (Moore et 
al., 1984). Muscle growth was influenced by severe 
hypothyroidism and was recovered to a normal level 
by the use of exogenous thyroid hormone (King 
& King, 1973). However, when evaluations were 
made on intact chickens, no improvement has been 
observed. In a study of May (1980), various essays 
were performed with broilers using exogenous T3 and 
T4. No improvements on BW or feed conversion rate 
were obtained, although some treatments resulted 
in high plasmatic level of the tested substances. The 
author, however, observed some growth stimulus 
of sex-linked dwarf chicks by the administration of 
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either T3 or T4. Interestingly, continuous exogenous 
use of T3 in broiler diet reduced growing of the 
chickens (Decuypere et al., 1987).
Why are exogenous 
hormones not used in 
chickens?
Here are the main reasons, already referred to 
before (Anderson & Gernat, 2004; Penz, 2012), we 
suggest that general poultry business related people 
should be sure about: 
1.  It is illegal. In most countries there is specific 
legislation.
2.  There is no technical reason: research 
does not show advantages in performance 
of intact poultry, thus there would be 
no justification to use such substances in 
commercial production. 
3.  Practical reason: Depending on the 
substance, it should be injected individually 
or through catheter implantation be liberated 
at pulsatile frequencies in order to mimic 
the natural process. Considering that only 
in Brazil more than six billion broilers are 
produced annually, it seems really not a 
feasible procedure.
4.  Cost: Substances like chicken GH are only 
available in order to attend low quantity 
demands of research laboratories. Therefore, 
these substances are of high cost, what 
would not be compatible with the low profit 
reality of the commercial poultry business. 
There is no high commercial production of 
these substances, nor is there demand for it. 
5.  Finally, it has to be considered that the 
poultry industry is highly professional, with 
quality requirements of the international 
market to be met. Therefore, it is an activity 
performed with zeal, the companies taking 
care of the respective brand. In the market, 
one, only one quality deviation may be 
enough to bring a long high-quality history 
down to almost nothing. There is no room for 
the use of questionable or illegal substances, 
like hormones, in this business. 
What makes broilers grow 
so fast?
The high capacity of body weight gain we see 
in broilers is the result of decades of investments 
in scientific research generating great genetic 
impacts and improvements in the environmental 
areas (nutrition, health, housing and general 
management). As an example in the nutrition area, 
broilers consume a diet balanced considering the 
level of amino acids, macro- and micro-minerals 
and vitamins, besides satisfying the required energy. 
Therefore, commercial chickens receive the nutrients 
they need to express their genetic potential.
But it is in the genetic area where the greatest 
improvements have occurred. An interesting study 
that shows it was developed by Havenstein et al., 
(2003a,b) in North Carolina, which compared 
a broiler strain maintained nonselected to the 
genetically selected counterparty, both using the 
old 1957- and the new 2001-diet. There was some 
advantage by using the modern diet on the old 
strains (8.5% for BW, 10,1% for FCR, and no gain 
for breast yield), and a much better gain using the 
modern diet on the selected broilers (27.8% for 
BW, 16% for FCR, and 14.7% for breast yield). 
However, evaluating the advantage of the selected 
genetic strain over the unselected ones showed a 
much higher impact: gain of 320% for BW, 20% 
for FCR, and 60.1% for breast yield. Therefore, here 
is the “magic bullet” responsible for the fantastic 
development of broiler chickens. The authors 
concluded that “genetic selection brought about by 
commercial breeding companies responds for about 
85 to 90% of the change that has occurred in broiler 
growth rate over the past 45 yr, while nutrition has 
provided 10 to 15% of the change” (Havenstein et 
al., 2003a).
Is there a relationship 
between dietary cholesterol 
and plasma cholesterol 
levels?
Eggs are a high nutritional-value food, able 
to provide most of our daily dietary requirements 
and functional factors. Furthermore, in the 
technological point of view, coagulating and 
emulsifying properties allow its remarkable use in 
the food industry. It is well known that the egg is an 
excellent source of digestible protein with balanced 
amino acid composition and antioxidant activity 
(Sakanaka et al., 2000, Sakanaka et al., 2004). 
Evaluating its contribution in the American diet, 
Song et al. (2000) found that daily nutrient intake, 
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those with LDL/HDL ratio ≤5 and triglycerides ≤202 
mg/dl. Similar results were observed by Assmann et 
al., (1998), who reported increase of 26.9% in CHD 
risk in individuals with combined LDL/HDL ratio >5 
and hypertriglyceridaemia.
The effect of dietary cholesterol on changes 
of serum lipids and lipoproteins profile, and its 
relationship with CHD has been an issue of prospective 
investigation and several debates. Simple regression 
analysis of data from clinical and epidemiological 
surveys has shown positive correlation between 
cholesterol intake and both plasma cholesterol level 
(McNamara, 2000a) and CHD mortality (LaROSA 
et al., 1990; Artaud-Wild et al., 1993; Kromhout 
et al., 1995; McNamara, 2000b). But, with the 
current understanding, dietary cholesterol is not an 
independent variable influencing plasma cholesterol 
and lipoproteins. Multivariate analysis is the more 
appropriated in order to minimize confounding by 
other dietary factors (such as saturated fats, dietary 
fiber, polyunsaturated fats, and trans fat), avoiding 
wrong outcomes about relative risk of CHD. 
Several cholesterol-rich foods are also a natural 
source of saturated fats (SFAs), which have a 
consistent positive correlation with levels of plasma 
cholesterol, lipoproteins, and CHD (Kromhout et al., 
1995; Hu et al., 1997; Clarke et al., 1997; Howell et 
al., 1997; McNamara, 2000b). Isocaloric replacement 
of SFAs by carbohydrates for 10% of dietary calories 
results in blood total cholesterol dropping of 14-20 
mg/dl (Mensink & Katan, 1992; Clarke et al., 1997; 
Mensink et al., 2003). According to Mensink et al., 
(2003), LDL and HDL levels fall about 1.24 and 0.39 
mg/dl respectively when saturated fats constituting 
1% of dietary energy are isoenergetically replaced 
by carbohydrates, resulting in a discrete effect on 
LDL/HDL ratio. 
Data from epidemiologic surveys and controlled 
clinical trials have indicated that replacing saturated 
fat with unsaturated fat is more effective in 
lowering risk of CHD than simply reducing total 
fat consumption (Hu et al., 2001; Hu & Willett, 
2002). Monounsaturated fats (MUFAs) and 
polyunsaturated fats (PUFAs) are inversely associated 
with serum lipids and lipoproteins, presenting a 
substantial benefit in attenuate CHD risk (Jakobsen 
et al., 2009). It is also known that MUFAs and PUFAs 
have biologically significant effects on levels of total 
cholesterol and LDL/HDL ratio. Predicted changes 
on lipids and lipoproteins profile as a consequence 
of dietary intervention are summarized on Figure 
1, based on Mensink & Katan (1992) and Mensink 
et al., (2003). Using data from 27 trials, Mensink 
except fiber and vitamin B6, was significantly higher 
in egg consumers than those subjects eating free-
egg diets. 
Nutraceutical factors also give eggs an important 
multifunctional role in human diet (Stadelman, 
1999). For instance, egg yolk is a highly bioavailable 
source of lutein and zeaxanthin, which are 
carotenoids with pharmacological properties, mainly 
in the prevention of degenerative eye diseases 
(Handelman et al., 1988; Sommerburg, 1999; Miller 
et al., 1996; Ribaya-Mercado & Blumberg, 2004). 
According to Handelman et al., (1999), lutein and 
zeaxanthin levels in blood increase significantly after 
dietary supplementation with egg yolk.
However, despite such nutritional and functional 
quality, people have a negative concept regarding 
to egg consumption. It continues to be viewed 
as a “bad food” by the general population. The 
main reason is because of its high cholesterol 
content (around 200 mg in a medium-size egg), 
what generates restrictive recommendations of its 
inclusion in our regular diets, often associating it to 
incidence of coronary heart disease (CHD). It is usual 
to assume that cholesterol-rich foods, especially 
eggs, can raise blood cholesterol and thus increase 
the risk of heart disease. Recent findings do not 
support this hypothesis, and dietary guidelines are 
being revised concerning egg consumption in order 
to keep a good diet quality (Kritchevsky, 2004; Lee 
& Griffin, 2006; Gray & Griffin, 2009).
Cardiovascular problems in humans are in fact 
linked to dyslipidemia. Clearly, high levels of fats 
(triglycerides) and cholesterol in blood, as well as 
changes in distribution of low density lipoprotein 
cholesterol (LDL) and high density lipoprotein 
cholesterol (HDL) are independent risk factors 
associated to development of CHD (LaROSA et 
al., 1990; Artaud-Wild et al., 1993; Sharrett et 
al., 2001; D’Agostino et al., 2001; Santos Filho 
& Martinez, 2002). The CHD risk increases 27% 
in men and 34% in women with elevated total 
plasma cholesterol (≥ 200 mg/dl), as estimated by 
Wilson et al., (1998). For each unit elevation in 
plasma triglycerides, the meta-analysis carried out 
by Austin and co-workers (1998) showed that CHD 
risk increases 14% in men and 37% in women. On 
the other hand, Gordon et al., (1989) reported that 
1 mg/dl increase in HDL cholesterol was associated 
with significant decrease in CHD risk (3.7% for men 
and 4.7% in women). Yet Manninen et al., (1992) 
used LDL/HDL ratio predictor of cardiac events. 
Subjects with LDL/HDL ratio >5 and triglycerides 
>202 mg/dl had relative risk of 3.8 higher than 
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and Katan (1992) estimated that direct isocaloric 
replacement of SFAs by PUFAs lead to a fall in total 
cholesterol of 2.1 mg/dl and LDL cholesterol of 1.8 
mg/dl per percent of energy. These results were 
confirmed by Mensink et al., (2003) evaluating data 
from 60 controlled trials (total cholesterol decrease 
about 2.2 mg/dl and LDL cholesterol falling by 1.97 
mg/dl per percent of energy). According to Clarke 
et al., (1997), total cholesterol decreases about 15 
mg/dl by direct replacement of 5% of energy as 
SFAs by PUFAs, and 9 mg/dl changing 5% calories 
as SFAs by MUFAs. Hu and co-workers (1997) 
reported that each increase of 5% of energy intake 
from saturated fats, as compared with equivalent 
energy from carbohydrates, was associated with 
a 17% increase in the CHD risk in women. In the 
same publication, the authors estimated that direct 
replacement of 5% of calories from saturated fats 
by unsaturated fats would reduce risk in 42%.
Diets characterized by 
a pattern high in fats and 
cholesterol (from animal 
products) are frequently poor in 
cereals, vegetables, and fruits, 
leading to a low level of dietary 
fiber. This is an important point 
since most of epidemiological 
studies suggest inverse 
relationship between dietary 
fiber and CHD. Brown et al., 
(1999) quantified cholesterol-
lowering effect of major dietary 
fibers, observing that soluble 
fiber (2-10 g/day) was associated 
with discrete but significant 
reduction in plasma total 
cholesterol (-1.7 mg/dl/g soluble 
fiber) and LDL cholesterol (-2.2 
mg/dl/g soluble fiber). According 
to Pereira et al., (2004), each 10 
g/day increment in total dietary 
fiber decreases by 14% the risk 
of all coronary events and by 
27% the risk of coronary death. 
As reported by Dauchet, et al., 
2006, CHD risk was reduced 
by 4% for each additional daily 
portion of fruit and vegetable 
intake and by 7% for fruit 
intake. In overall, it is more 
important to control intakes of 
saturated and trans fats as well 
as to increase consumption of 
vegetables, fruits, and foods rich 
in unsaturated fats to prevent 
coronary and arterial events, as stated by Hu & Willet, 
2002):
“Compelling evidence from metabolic 
studies, epidemiologic investigations, and 
clinical trials in the past several decades 
converges to indicate that at least 3 dietary 
strategies are effective in preventing CHD: 
substitute unsaturated fats (especially 
polyunsaturated fat) for saturated and trans-
fats; increase consumption of omega-3 fatty 
acids from fish oil or plant sources; and 
consume a diet high in fruits, vegetables, nuts, 
and whole grains and low in refined grains. A 
combination of these approaches can confer 
greater benefits than a single approach. 
However, simply lowering the percentage of 
energy from total fat in the diet is unlikely to 
improve lipid profile or reduce CHD incidence.” 
(Hu & Willett, 2002). 
Figure 1 - Mean changes in levels of lipids and lipoproteins in blood when 
1% of dietary energy from carbohydrates is replaced isoenergetically with 
different types of fats. (LDL: Low density lipoprotein cholesterol; HDL: 
high density lipoprotein cholesterol; SFA: saturated fatty acids; MUFAs: 
monounsaturated fatty acids; PUFAs: polyunsaturated fatty acids). Source: 
Adaptated from a) Mensink and Katan (1992) and b) Mensink et al.,(2003). 
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 Since interaction among 
different factors must be taken 
into account, publications 
considering the set of dietary 
features have demonstrated 
the realistic effects on plasma 
cholesterol levels and CHD 
risk. When multivariate analysis 
include saturated fats and fiber 
intake, dietary cholesterol (also 
from egg) has a slight influence 
on levels of blood cholesterol, 
LDL, and HDL. As summarized 
in Figure 2, predictions are able 
to shown that a 100 mg/day 
change in dietary cholesterol only 
increases, on average, plasma 
total cholesterol by 2.2-2.7 mg/dl, 
LDL cholesterol by 1.9 mg/dl, and 
HDL by 0.4 mg/dl (McNamara, 
1995; McNamara, 2000a; 
McNamara 2000b). Furthermore, 
it is important to observe the considerable 
heterogeneity degree between individuals. Majority 
(75-85%) of individuals are classified as hypo-
responders (plasma cholesterol varies by 1.4 mg/dl 
per 100 mg/day change in dietary cholesterol), and 
minority exhibit hyper-responder behavior (plasma 
cholesterol varies by 3.9 mg/dl per 100 mg/day 
change in dietary cholesterol) (McNamara, 2000a; 
Fernandez, 2010). 
Based on all evidences, it is convenient to accept 
that dietary cholesterol has a modest effect in 
changing the level of circulating cholesterol and 
lipoproteins of non-diabetic population (McNamara, 
2000a; Kritchevsky & Kritchevsky, 2000). Overall, in 
order to prevent coronary events, it is more important 
to control the intake of saturated and trans fats as 
well as increase vegetables and fruits consumption. 
Eggs, which are a nutritive food with relative low 
levels of SFAs (1.6 g in a medium-size egg), are not 
significantly associated with hypercholesterolemia or 
even cardiovascular disease incidence. Its moderate 
consumption should be permanently encouraged 
as part of a healthy diet, as stated by McNamara 
(2000a) and Gray & Griffin (2009):
“Recommendations that egg consumption 
be restricted by the general population are 
not supported by the experimental data and, 
as noted by the reviews published in this issue 
of the journal, limit a valuable and affordable 
source of high quality nutrition from the diet. 
The nutrient density of eggs and their role in 
a heart healthy diet need to be reconsidered 
in light of the changing dietary patterns in 
the population and the increase in obesity 
in the American public. There is no scientific 
justification for population-wide specific 
limits on weekly egg consumption, and such 
restrictions only serve to divert attention 
away from effective dietary and life-style 
interventions to lower CHD risk.” (McNamara, 
2000a).
“The egg is a nutrient-dense food, a 
valuable source of high quality protein and 
essential micronutrients that is not high in SFA 
or in energy. In the current difficult financial 
climate, eggs can play a useful role as a 
relatively inexpensive source of nutrition for 
all and especially for people on low incomes.” 
(Gray & Griffin, 2009).
Are there advantages of 
organic over the conven-
tional poultry products?
The main reasons people prefer alternative 
products, especially organic food, over the 
conventional is because they believe there is a 
nutritious advantage, that they are healthier, or 
because it fits better in their lifestyle. There is not 
much to discuss on the last item, or even on a fourth 
one which would be related to taste, but we shall 
address the nutritious and health issue. 
Figure 2 - Changes in levels of total cholesterol and lipoproteins in 
blood following increase of dietary cholesterol by 100 mg/day. (LDL: Low 
density lipoprotein cholesterol; HDL: high density lipoprotein cholesterol). 
Source: Adaptated from McNamara (2000a). 
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A study of the UK Food Standard Agency observed 
that the nutrient levels in foods vary depending on 
many different factors. These include freshness, 
storage conditions, crop variety, soil conditions, 
weather conditions and how animals are fed. All 
crops and animals therefore vary in nutrient level to 
some extent. The available evidence shows that the 
nutrient levels and the degree of variation are similar 
in food produced by both organic and conventional 
agriculture. All processed food, including organic, 
has a nutrient content that is dependent on the 
nutrient content of ingoing ingredients, recipe 
and cooking methods. The impact of processing 
on nutrient levels will be the same for products 
made from organically and conventionally produced 
ingredients. In the same report the agency concludes 
that there is no scientific evidence that organic food 
is any different in nutrition composition or in safety 
than the conventional food. This study is supported 
by a systematic review on 52,471 articles which 
did not find any significant nutritional differences 
between conventional and organic foodstuffs 
(Dangour et al., 2009).
Another systematic review (Dangour et al., 
2010), which considered 98,727 scientific articles, 
focused on 12 relevant studies about possible 
human benefits of organic food consumption. 
The conclusion was that evidence is lacking for 
nutrition-related health effects that result from the 
consumption of organically produced foodstuffs, 
with the exception of one report showing that 
strictly consumption of diary organic products was 
related to lower levels of eczema in infants.
It is also usual people relate organic products to 
lower hazards or even to risk free. So far, there is 
no support for such belief, a good contrary example 
being the outbreak of food contamination occurred 
Europe in 2011, which involved the consumption 
of bean sprouts from an organic farm in northern 
Germany. This wide known outbreak was caused by 
the E coli (Shiga toxin-producing O104:H4), resulted 
in thousands of humans infected and dozens of 
fatalities (Sample 2011; Werber et al., 2012).
The scientific community and governmental 
agencies have the duty of inform the consumers 
about the scientific findings about all different ways 
that food is produced and their real benefits or health 
risks. Paying more for an alternative produced food 
is a personal decision related to freedom of choice, 
which according the literature evidence, cannot be 
based on any nutritious or heath benefits.
Concluding remarks
It is our understanding that the consumption 
of poultry meat, as well as eggs, should be 
encouraged, considering it offers high quality 
nutrients at prices most of world population can 
afford. Concerning some myths, it is important to 
make clear that worldwide there is a sophisticated 
professional poultry industry which generates jobs, 
food and wealth, and does it with responsibility. 
Perhaps the industry itself should be more emphatic 
about showing the quality of its products. There 
are important initiatives going on in Associations 
and Institutes like the Brazilian Eggs Institute 
(Instituto Ovos Brasil). However, occasionally 
wrong marketing strategies come afloat from some 
industries worldwide. When a customer sees a label 
asserting that it is “produced without hormones”, 
his reaction is that usually the products in the 
marked are loaded with hormones. Definitely, such 
marketing strategies do not help. 
Finally, it seems appropriate to stress out the 
importance of science-based conclusions. According 
to Gleiser (2010), science offers the possibility of 
freedom from the unknown, the irrational. He states 
that by giving the autonomy to think by himself, 
science offers freedom through knowledge-based 
choices; and by transforming mystery into challenge 
science adds a new dimension to life, now free from 
dogmas.
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